Former Novo Nordisk employee plans to revolutionize market for insulin pens
Ole Kjerkegaard Nielsen has devoted most of his life to CSR and now he and collaborative partner Michael Ejstrup Hansen are ready to send new insulin pen on the market.
BY BENJAMIN WERNER CHRISTENSEN, FINANS, TRANSLATED BY NIELSINE NIELSEN
The world' poorest diabetes patients have billions to save and better every-day lives ahead of them, if the ambitions and dreams of the former Novo Nordisk Project Director Ole Kjerkegaard Nielsen and his partner Michael Ejstrup Hansen come to fruition.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk submits obesity drug for FDA approval
For subscribers
